Cabaletta Bio, Inc. (CABA) Misses Q2 EPS by 1c

Cabaletta Bio, Inc. (NASDAQ: CABA) reported Q2 EPS of ($0.56), $0.01 worse than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Cabaletta Bio, Inc. (CABA) click here.

You May Also Be Interested In

• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Xerox Corp. (XRX) gains on report of SEWP VI contract
• Lockheed Martin bids for NATO modeling and simulation contract